Core signal
What: NICE (UK) recommends Parent Training and Behavioral Intervention as the first-line option for children and adolescents with ADHD.
PRO Summary
How to read this card
Evidence scope
Who: Pharmacotherapy is suggested as a stepwise approach, to be considered when Non-Pharmacological Interventions are insufficient.
Use principle
Result: This is a comprehensive Clinical Guideline encompassing Environmental Modification, school support, and Psychoeducation as part of a multi-layered support system.
Evidence Reading
What to check when interpreting the evidence
Study typeType: Guideline
PopulationPopulation: Children and Adolescents (5-17)
EvidenceEvidence: Original Link
UseResult: This is a comprehensive Clinical Guideline encompassing Environmental Modification, school support, and Psychoeducation as part of a multi-layered support system.
Consultation Prep
Turn the card into questions before consultation
You can try structuring daily routines at home to match your child's ADHD characteristics.
Record this as a question or context point before professional consultation.
Communicate regularly with the school and discuss Classroom Management adjustments.
Record this as a question or context point before professional consultation.
Consider participating in a Parent Training program after consulting with a professional.
Record this as a question or context point before professional consultation.
Limits
PRO use principles
Evidence scope
Limitation: Based on the UK healthcare system, direct application to the Korean context may differ.
Hold individual application
Do not transfer group-level findings, guideline summaries, or program effects directly to an individual case without considering fit, feasibility, and limits.
Use principle
Disclaimer: This information summarizes recent research findings and does not replace medical diagnosis or treatment. For health-related decisions, please consult a qualified professional.
Professional consultation
ADHD assessment, medication decisions, school support, and care planning should be discussed with a qualified professional.
Scope Note
Notice and limits
Limitation: Based on the UK healthcare system, direct application to the Korean context may differ.
Disclaimer: This information summarizes recent research findings and does not replace medical diagnosis or treatment. For health-related decisions, please consult a qualified professional.